Status:
ACTIVE_NOT_RECRUITING
Virological and Immunological Monitoring in Patients (suspected Of/confirmed With) COVID-19
Lead Sponsor:
University Hospital, Ghent
Collaborating Sponsors:
Fund for Scientific Research, Flanders, Belgium
Chan Zuckerberg Initiative
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
This study is a prospective, observational multicentric study. The study population entails adult patients hospitalized with a high clinical suspicion of COVID-19 and consists of two study arms (SARS-...
Eligibility Criteria
Inclusion
- Upper or lower respiratory symptoms and temperature ≥37.5°C, with high clinical suspicion of COVID-19
- Requiring hospitalization
Exclusion
- Known pregnancy at the time of screening
- Inability to give informed consent or absence of legal representative who can give informed consent.
Key Trial Info
Start Date :
March 23 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2024
Estimated Enrollment :
109 Patients enrolled
Trial Details
Trial ID
NCT04904692
Start Date
March 23 2020
End Date
September 30 2024
Last Update
September 19 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
AZ Jan Palfijn
Ghent, Oost-Vlaanderen, Belgium, 9000
2
AZ Maria Middelares
Ghent, Oost-Vlaanderen, Belgium, 9000
3
UZ Gent
Ghent, Oost-Vlaanderen, Belgium, 9000